Tournament: New York City Invitational | Round: 1 | Opponent: Harrison AA | Judge: Brendon Morris
P1: Evergreening
Evergreening keeps Drug Prices high.
Amin 18 Tahir Amin 6-27-2018 "The problem with high drug prices isn't 'foreign freeloading,' it's the patent system" High drug prices caused by US patent system, not 'foreign freeloaders' (cnbc.com) https://www.cnbc.com/2018/06/25/high-drug-prices-caused-by-us-patent-system.html (co-founder of nonprofit I-MAK.org)
'Evergreening' Instead of of going to new medicines.......are still not able to afford treatment.
High Drug Prices forces patients to go underground for drugs.
- AT Medicare CP – won’t cover Drugs – CP can’t fiat coverage
Bryant 11 Clifton Bryant 2011 “The Routledge Handbook of Deviant Behaviour” (former professor of sociology at VA Tech)
Now, the field of medicine is able to achieve seemingly miraculous results, through organ transplantation, reviving patients who have been "clinically" dead, and curing supposedly "incurable diseases." As the cost and the difficulty of obtaining medical care and medicines increase, the implications for increased crime and deviance become almost limitless.
That kills Millions.
Greenberger 20 Phyllis E. Greenberger 12-3-2020 "Counterfeit Medicines Kill People" https://www.healthywomen.org/health-care-policy/counterfeit-medicines-kill-people/who-suffers-because-of-counterfeit-drugs (HealthWomen’s Senior Vice President of Science and Health Policy)
Over 1 million people die each year from fake drugs. The U.S. Department of Justice found that, in at least one case, these counterfeit drugs had been sold through a fraudulent online pharmacy.
Counterfeit Drugs cause Anti-Biotic Resistance.
Jahnke 19 Art Jahnke 1-14-2019 "How Bad Drugs Turn Treatable Diseases Deadly" https://www.bu.edu/articles/2019/how-bad-drugs-turn-treatable-diseases-deadly/ (Senior editor Art Jahnke began his career at the Real Paper, a Boston area alternative weekly. He has worked as a writer and editor at Boston Magazine, web editorial director at CXO Media, and executive editor in Marketing and Communications at Boston University, where his work was honored with many awards. Art has served on the editorial board of the Boston Review and has taught at Harvard University summer school and Emerson College.)
Four decades later as a Boston University professor of biomedical engineering and materials science and engineering, Zaman was reminded of the dangers of low-quality drugs in his native country when he learned that more than 200 people in the city of Lahore died after being treated with an adulterated version of a hypertension drug. In Pakistan, for example, a country of nearly 200 million people, only a handful of federal inspectors monitor the quality of drug manufacturing.
Extinction - generic defense doesn’t apply.
Srivatsa 17 Kadiyali Srivatsa 1-12-2017 “Superbug Pandemics and How to Prevent Them” https://www.the-american-interest.com/2017/01/12/superbug-pandemics-and-how-to-prevent-them/ (doctor, inventor, and publisher. He worked in acute and intensive pediatric care in British hospitals)
It is by now no secret that the human species is locked in a race of its own making with “superbugs.” A flu-like disease could kill more than 33 million people in 250 days.
High Drug Prices pushes people into poverty – our internal is causal.
Hoban 10 Rose Hoban 9-13-2010 "High Cost of Medicine Pushes More People into Poverty" https://www.voanews.com/science-health/high-cost-medicine-pushes-more-people-poverty (spent more than six years as the health reporter for North Carolina Public Radio – WUNC, where she covered health care, state health policy, science and research with a focus on public health issues. She left to start North Carolina Health News after watching many of her professional peers leave or be laid off of their jobs, leaving NC with few people to cover this complicated and important topic. ALSO cites Laurens Niens who is a Health Researcher at Erasmus University Rotterdam)
Health economist Laurens Niëns found that drugs needed to treat chronic diseases could be considered unaffordable for many people in poor countries. So often, governments think they pay a good price for the medicines when they procure them from the producer. However, before such a medicine reaches a patient, markups are sometimes up to 1,000 percent."
This is a form of pharm cap – exploiting marginalized groups in the third world.
Lift Mode 17 3-10-2017 "Pharmaceutical Colonialism” https://medium.com/@liftmode/pharmaceutical-colonialism-3-ways-that-western-medicine-takes-from-indigenous-communities-3a9339b4f24f (We at Liftmode.com are a team of professionals from a variety of backgrounds, dedicated to the mission of providing the highest quality and highest purity nutritional health supplements on the market. We look specifically for the latest and most promising research in the fields of cognition enhancement, neuroscience and alternative health supplements, and develop commercial strategies to bring these technologies to the marketplace.)
3. Cost of medicine as a form of debt One of the biggest methods of extracting money from rural and indigenous communities is through increased costs of medication. The slums in Brazil highlight the blatant inequality between nations and people.
The Alternative to the Aff isn’t no medicine but exploitive medicine – the Plan’s orientation is a sequencing strategy to resistance.
Ahmed 20 A Kavum Ahmed 6-24-2020 "Decolonizing the vaccine" https://africasacountry.com/2020/06/decolonizing-the-vaccine (A. Kayum Ahmed is Division Director for Access and Accountability at the Open Society Public Health Program in New York and teaches at Columbia University Law School.)
Reflecting on a potential COVID-19 vaccine trial during a television interview in April, a French doctor stated, Resistance to this colonial power requires the decolonization of the vaccine.
1AC: Plan
Plan – The member nations of the World Trade Organization ought to reduce intellectual property protections for medicines by implementing a one-and-done approach for patent protection.
Part 2 is Solvency
The Plan solves Evergreening.
Feldman 3 Robin Feldman 2-11-2019 "‘One-and-done’ for new drugs could cut patent thickets and boost generic competition" https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/ (Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson ’54 Distinguished Professor of Law Chair, and Director of the Center for Innovation)
I believe that one period of protection should be enough.And right now, the incentives for creating patent walls are just too great.
P2: FW
The standard is maximizing expected well-being,